Sage Therapeutics to Present at BMO Prescriptions for Success Healthcare Conference
June 18 2019 - 6:30AM
Business Wire
Sage Therapeutics (NASDAQ: SAGE), a biopharmaceutical company
developing novel medicines to treat life-altering central nervous
system (CNS) disorders, today announced that the Company will
present at the BMO Prescriptions for Success Healthcare Conference
on Tuesday, June 25, 2019 at 8:40 a.m. EST in New York, NY.
A live webcast of the presentation can be accessed on the
investor page of Sage's website at investor.sagerx.com. A replay of
the webcast will also be archived for up to 30 days on Sage's
website following the conference.
About Sage TherapeuticsSage Therapeutics is a
biopharmaceutical company committed to developing novel medicines
to transform the lives of patients with life-altering central
nervous system (CNS) disorders. Sage’s portfolio of novel compounds
targets critical receptor systems in the brain and includes the
first treatment specifically approved by the U.S. Food and
Drug Administration for postpartum depression as well as
compounds being developed as potential treatments for diseases such
as major depressive disorder, insomnia, bipolar disorder and
essential tremor. For more information, please
visit www.sagerx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190618005293/en/
Investor Contact:Maren Killackey,
617-949-4113maren.killackey@sagerx.com
Media Contact:Alexis Smith,
617-588-3740alexis.smith@sagerx.com
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Sep 2024 to Oct 2024
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Oct 2023 to Oct 2024